TY - JOUR AU - Giorgio, Antonio AU - Luca, Massimo De AU - Gatti, Pietro AU - Matteucci, Paolo AU - Giorgio, Valentina PY - 2019 TI - Can contrast-enhanced ultrasound with perfluorobutane add value in detection of hepatocellular carcinoma in cirrhosis during surveillance? JF - Quantitative Imaging in Medicine and Surgery; Vol 9, No 8 (August 27, 2019): Quantitative Imaging in Medicine and Surgery Y2 - 2019 KW - N2 - Ultrasound (US) plays a pivotal role in the recognition of hepatocellular carcinoma (HCC) in cirrhosis (1). HCC represents the sixth most common malignancy and the fourth most frequent cause of cancer-related death in the world (2). Since the early 1980s, the US has described the fundamental findings of the HCC nodules appearing in a cirrhotic liver and significantly contributed to the knowledge of the natural history of this malignancy (3). UR - https://qims.amegroups.org/article/view/27823